Parametric Portfolio Associates’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-131,590
Closed -$500K 4055
2020
Q1
$500K Sell
131,590
-13,640
-9% -$58.8K ﹤0.01% 3163
2019
Q4
$739K Sell
145,230
-26,898
-16% -$142K ﹤0.01% 3212
2019
Q3
$870K Sell
172,128
-109,719
-39% -$547K ﹤0.01% 3096
2019
Q2
$1.74M Buy
281,847
+79,392
+39% +$383K ﹤0.01% 2761
2019
Q1
$939K Sell
202,455
-58,383
-22% -$264K ﹤0.01% 3061
2018
Q4
$1.1M Buy
260,838
+122,343
+88% +$623K ﹤0.01% 2928
2018
Q3
$868K Sell
138,495
-108,604
-44% -$834K ﹤0.01% 3175
2018
Q2
$1.99M Buy
247,099
+68,893
+39% +$526K ﹤0.01% 2700
2018
Q1
$1.33M Sell
178,206
-15,825
-8% -$105K ﹤0.01% 2863
2017
Q4
$1.15M Buy
194,031
+74,465
+62% +$452K ﹤0.01% 2945
2017
Q3
$880K Buy
119,566
+6,513
+6% +$41.4K ﹤0.01% 3109
2017
Q2
$768K Buy
113,053
+11,804
+12% +$87.1K ﹤0.01% 3128
2017
Q1
$956K Buy
101,249
+25,413
+34% +$254K ﹤0.01% 2880
2016
Q4
$655K Buy
+75,836
New +$561K ﹤0.01% 3052
2015
Q4
Sell
-22,745
Closed -$130K 4007
2015
Q3
$130K Sell
22,745
-37,530
-62% -$288K ﹤0.01% 3164
2015
Q2
$450K Buy
60,275
+18,009
+43% +$109K ﹤0.01% 3347
2015
Q1
$253K Sell
42,266
-50,463
-54% -$318K ﹤0.01% 3649
2014
Q4
$701K Sell
92,729
-50,152
-35% -$300K ﹤0.01% 3055
2014
Q3
$742K Buy
142,881
+34,004
+31% +$169K ﹤0.01% 2916
2014
Q2
$469K Buy
108,877
+949
+0.9% +$3.62K ﹤0.01% 3243
2014
Q1
$441K Buy
107,928
+50,709
+89% +$259K ﹤0.01% 3246
2013
Q4
$305K Buy
+57,219
New +$252K ﹤0.01% 3416

Other funds holding PGNX